Inventor
LINGARD IAIN
IT20 patents
⚠️ This page may combine multiple inventors who share the name “LINGARD IAIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
8 patentsUS10183940B2Jan 22, 2019
Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists
BOEHRINGER INGELHEIM INT2 citations73
US10071974B2Sep 11, 2018
Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists
BOEHRINGER INGELHEIM INT2 citations73
US10501440B2Dec 10, 2019
Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
BOEHRINGER INGELHEIM INT4 citations72
US10640486B2May 5, 2020
Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
BOEHRINGER INGELHEIM INT4 citations71
US10399961B2Sep 3, 2019
Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
BOEHRINGER INGELHEIM INT4 citations71
US10577336B2Mar 3, 2020
Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists
BOEHRINGER INGELHEIM INT1 citations62
US12091399B2Sep 17, 2024
Phenyltetrazole derivatives as plasma kallikrein inhibitors
BOEHRINGER INGELHEIM INT0 citations51
US9308194B2Apr 12, 2016
Indanyloxyphenylcyclopropanecarboxylic acids
BOEHRINGER INGELHEIM INT1 citations51
CENTREXION THERAPEUTICS CORP
3 patentsUS10166214B2Jan 1, 2019
Somatostatin receptor subtype 4 (SSTR4) agonists
CENTREXION THERAPEUTICS CORP4 citations83
US9789082B2Oct 17, 2017
Somatostatin receptor subtype 4 (SSTR4) agonists
CENTREXION THERAPEUTICS CORP5 citations83
US10675268B2Jun 9, 2020
Somatostatin receptor subtype 4 (SSTR4) agonists
CENTREXION THERAPEUTICS CORP2 citations72
GIOVANNINI RICCARDO
3 patentsUS9012489B2Apr 21, 2015
Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
GIOVANNINI RICCARDO2 citations61
US8648070B2Feb 11, 2014
Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
GIOVANNINI RICCARDO0 citations39
US8648118B2Feb 11, 2014
Bicyclic ring system substituted amide functionalised phenols as medicaments
GIOVANNINI RICCARDO0 citations39
AMGEN INC
3 patentsUS12448396B2Oct 21, 2025
Methods of using heterocyclic compounds as Delta-5 Desaturase inhibitors
AMGEN INC1 citations56
US11512097B2Nov 29, 2022
Heterocyclic compounds as Delta-5 desaturase inhibitors and methods of use
AMGEN INC0 citations54
US12473289B2Nov 18, 2025
Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
AMGEN INC0 citations46